Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1523 results found
2025 ∙ Mirza, A. A. Almalki, A. H. Noori, F. A. Neazy, S. A. Dahm, V. Bajin, M. D. Lin, V. Y.
Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis
All age groups COVID-19 Safety
Rating:
Low
2025 ∙ Rudolph, A. E. Al Akoury, N. Bogdanenko, N. Markus, K. Whittle, I. Wright, O. Haridy, H. Spinardi, J. R. McLaughlin, J. M. Kyaw, M. H.
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Moreira da Cunha, N. Tzirita, S. Gobbo, E. Herzig van Wees, S.
Factors influencing adolescents' decision-making about COVID-19 vaccination: a systematic review with qualitative synthesis
Adolescents COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Zhao, T. Xu, Q. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.
Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Magalhaes, B. A. P. Medeiros Minasi, J. Lobato, R. C. Lemos, L. C. de Britto, L. S. Barros, R. M. de Martinez, A. M. B. da Hora, V. P.
Globally approved vaccines for COVID-19: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Zhang, C. Zhang, Y. Q. Liu, R. B. Ma, Y. T. Zhao, L. K. Yin, F. Q. Tu, J. Yao, Y. Y.
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Hoang, T. N. A. Byrne, A. Quach, H. L. Bannister-Tyrrell, M. Vogt, F.
How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Rahimi, H. K. Jasim, A. A. Rezahosseini, O. Harboe, Z. B.
Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis
Adults Older adults Pneumococcal disease Influenza COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2025 ∙ Ballivian, J. Parker, E. P. K. Berrueta, M. Ciapponi, A. Argento, F. Bardach, A. Brizuela, M. Castellana, N. Comande, D. Kampmann, B. Mazzoni, A. Sambade, J. M. Stegelmann, K. Xiong, X. Munoz, F. M. Stergachis, A. Buekens, P.
Immunogenicity of COVID-19 Vaccines During Pregnancy A Systematic Review and Comparison of Pregnant Versus Nonpregnant Persons
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
2025 ∙ Chen, J. Yang, C. Lin, W. Cheng, X. He, H. Li, X. Yu, J.
Immunogenicity, Safety, and Protective Efficacy of Mucosal Vaccines Against Respiratory Infectious Diseases: A Systematic Review and Meta-Analysis
All age groups COVID-19 Influenza RSV (Respiratory syncytial virus) Pertussis Tuberculosis Efficacy/effectiveness Safety Administration
Rating:
Critically low
Loading...